V
Violaine Giraud
Researcher at University of Paris
Publications - 36
Citations - 1578
Violaine Giraud is an academic researcher from University of Paris. The author has contributed to research in topics: Lung cancer & Nivolumab. The author has an hindex of 14, co-authored 31 publications receiving 1280 citations.
Papers
More filters
Journal ArticleDOI
Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability
Violaine Giraud,Nicolas Roche +1 more
TL;DR: Misuse of pressurized metered-dose inhalers, which is mainly due to poor coordination, is frequent and associated with poorer asthma control in inhaled corticosteroid-treated asthmatics, highlighting the importance of evaluating inhalation technique and providing appropriate education in all patients.
Journal ArticleDOI
Inhaler technique and asthma: feasability and acceptability of training by pharmacists.
TL;DR: Inhaler training by pharmacists in patients receiving inhaled corticosteroids by pressurised metered-dose inhaler or breath-actuated MDI is feasible and seams to improve inhaler technique, asthma control and adherence.
Journal ArticleDOI
Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis
Lucile Sesé,Hilario Nunes,Vincent Cottin,Shreosi Sanyal,Morgane Didier,Zohra Carton,Dominique Israel-Biet,Bruno Crestani,Jacques Cadranel,Benoit Wallaert,Abdellatif Tazi,Bernard Maitre,Grégoire Prévot,Sylvain Marchand-Adam,Stephanie Guillot-Dudoret,Annelyse Nardi,Sandra Dury,Violaine Giraud,Anne Gondouin,Karine Juvin,Raphael Borie,Marie Wislez,Dominique Valeyre,Isabella Annesi-Maesano +23 more
TL;DR: It is suggested that air pollution has a negative impact on IPF outcomes, corroborating the role of ozone on AEs and establishing, for the first time, the potential role of long-term exposure to PM10 and PM2.5 on overall mortality.
Journal ArticleDOI
Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer
Nadia Nathan,Violaine Giraud,Clément Picard,Hilario Nunes,Florence Dastot-Le Moal,Bruno Copin,Laurie Galeron,Alice De Ligniville,Nathalie Kuziner,Martine Reynaud-Gaubert,Dominique Valeyre,Louis-Jean Couderc,Thierry Chinet,Raphael Borie,Bruno Crestani,Maud Simansour,Valérie Nau,Sylvie Tissier,Philippe Duquesnoy,Lamisse Mansour-Hendili,Marie Legendre,Caroline Kannengiesser,Aurore Coulomb-L'Hermine,Laurent Gouya,Serge Amselem,Annick Clement +25 more
TL;DR: This first report of a germline molecular defect in SFTPA1 unveils the key role of SP-A1 in the occurrence of several chronic respiratory diseases, ranging from severe respiratory insufficiency occurring early in life to the association of lung fibrosis and cancer in adult patients.
Journal ArticleDOI
Immunotherapy revolutionises non-small-cell lung cancer therapy: Results, perspectives and new challenges.
Etienne Giroux Leprieur,Coraline Dumenil,C. Julié,Violaine Giraud,Jennifer Dumoulin,Sylvie Labrune,Thierry Chinet +6 more
TL;DR: Pembrolizumab, an anti-PD1 antibody, was reported to have great efficacy in the first-line treatment of PDL1 ≥ 50% tumours, and nivolumab failed to show any benefit compared with standard platinum-based CT, suggesting a new paradigm for the treatment of advanced NSCLC.